Dr.I.Unnikrishnan Namboothiri , Addl.Chief Physician of Itoozhi Ayurveda, India, was honoured by Dr. Antonio Morandi (Italy) at the SNA Oushadhasala campus for his best clinical paper presentation on the topic “Clinical Ophthalmology in Ayurveda”.

About Dr. Antonio Morandi, MD, PhD (1957, Firenze, Italy)

Dr. Antonio Morandi, MD, PhDA Medical Doctor, Specialist in Neurology and Ayurveda Vaidya (Ayurveda Academy, Pune, India and Joytinat International College of Ayurveda), Dr. Antonio Morandi is President of Ayurvedic Point srl a leading institution in Italy and Europe for therapy, research and education in Ayurveda. He is Director of the School of Ayurvedic Medicine Ayurvedic Point in Milan, the most important educational institution in Italy, which counts 150 students per year and whose syllabus is widely accepted in Europe. Ayurvedic Point has been recently ISO 9001 certified, an international quality certification, for its teaching activities. Dr. Morandi is also President of the Italian Scientific Society for Ayurvedic Medicine (S.S.I.M.A.), an association of medical doctors practicing Ayurveda, which is a founding member of the Italian Permanent Consensus Committee on Non Conventional Medicines. In 2003 he has been awarded with the honorary doctorate Ayurveda Acharya from the Ayurvedic Institute Ashtavaidyan Thaikat Mooss, Kerala, India. Director and Professor of Ayurveda section at the Post Doctoral specialization course in Health Sociology and Non Conventional Medicine, University of Bologna, Italy, Dr. Morandi has been called to teach Ayurveda in several Italian and foreign Universities. Dr. Morandi is also Scientific Director of the International Congress on Ayurveda Ayurveda: the meaning of life which will be held in Milan, Italy in March 2009. Member of several scientific committees and author of numerous publications, he is also Head of Medical Education of the European Institute of Vedic Sciences, France and directs the Medical Ayurvedic Center “Ayurvedic Point” in Milan, Italy.

Categories: Itoozhi News

Leave a Reply

Your email address will not be published.